CytomX Therapeutics
CTMX • NASDAQ
CytomX Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sean A. McCarthy, with a market cap of $977.1M.
Market Cap$977.1M
Employees122.0
CEOSean A. McCarthy
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
CytomX Therapeutics FAQ
Common questions about CytomX Therapeutics
CytomX Therapeutics is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $4.2M.
CytomX Therapeutics has approximately 122 employees.